SciELO - Scientific Electronic Library Online

 
vol.27 número6Evaluación del tratamiento de la fibrilación auricular valvular y no valvular y su relación con eventos adversos en pacientes hospitalizados en el servicio de urgencias de un hospital de tercer nivelPéptidos natriuréticos en la detección de disfunción ventricular izquierda en población de alto riesgo. Metaanálisis de pruebas diagnósticas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Cardiología

versión impresa ISSN 0120-5633

Resumen

MENDOZA, Fernan et al. Financial burden of atrial defibrillation in Colombia. Rev. Colomb. Cardiol. [online]. 2020, vol.27, n.6, pp.541-547.  Epub 01-Ago-2021. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2019.09.012.

Objective:

To determine the financial cost of atrial defibrillation in Colombia.

Materials and methods:

A retrospective study was carried out using health care data bases on patients with a diagnosis of atrial fibrillation. The patients were identified from the diagnoses recorded in ambulatory and hospital care registers, using the atrial fibrillation ICD-10 diagnostic (I48x). After the patients were identified, an algorithm was constructed by using the management guidelines for the disease and that simulated the natural history and care of the disease. A micro-costing technique was used in accordance with an official data base of a Colombian insurance Company, taking into account the natural history of the disease constructed.

Results:

The mean annual cost of a patient correctly diagnosed with atrial fibrillation is $6,218.179, that of the patient with an acute thrombo-embolic event or non-specific signs as a first manifestation of the disease is $23,665.300, and that of the patient with an infarction prior to the diagnosis of atrial fibrillation is $37,493.968.

Conclusions:

In terms of costs, the patient that is maintained under control, despite the technological costs of their control, is less costly than one that has acute episodes.

Palabras clave : Atrial fibrillation; Cross-sectional studies; Economy; Healthcare costs.

        · resumen en Español     · texto en Español     · Español ( pdf )